20733579

Source:http://linkedlifedata.com/resource/pubmed/id/20733579

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205314, umls-concept:C0450442, umls-concept:C0679622, umls-concept:C0920321, umls-concept:C1511636, umls-concept:C2703082
pubmed:issue	5
pubmed:dateCreated	2010-8-24
pubmed:abstractText	CYT997 is a novel microtubule inhibitor and vascular-disrupting agent with marked preclinical anti-tumour activity.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-10931600, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-12010363, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-12067983, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-12807934, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-12807936, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-14645433, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-14734457, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-15374879, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-16551862, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-16574998, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-17036040, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-17356709, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-17375046, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-18813353, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-18819993, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-19078952, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-19097774, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-19351751, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-19616947, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-19887548, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-8212530, http://linkedlifedata.com/resource/pubmed/commentcorrection/20733579-9262252
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370635
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/CYT997, http://linkedlifedata.com/resource/pubmed/chemical/Keratin-18, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Von Willebrand antigen, http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1532-1827
pubmed:author	pubmed-author:BurgeMM, pubmed-author:CoulthardAA, pubmed-author:CubittAA, pubmed-author:FrancesconiA BAB, pubmed-author:GriffinMM, pubmed-author:LickliterJ DJD, pubmed-author:McCarronJJ, pubmed-author:MilneRR, pubmed-author:RossAA, pubmed-author:SmithGG, pubmed-author:VaseyP APA, pubmed-author:WillePP, pubmed-author:WyldD KDK, pubmed-author:YeadonTT
pubmed:issnType	Electronic
pubmed:day	24
pubmed:volume	103
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	597-606
pubmed:dateRevised	2011-8-29
pubmed:meshHeading	pubmed-meshheading:20733579-Adult, pubmed-meshheading:20733579-Aged, pubmed-meshheading:20733579-Angiogenesis Inhibitors, pubmed-meshheading:20733579-Antineoplastic Agents, pubmed-meshheading:20733579-Cell Count, pubmed-meshheading:20733579-Endothelial Cells, pubmed-meshheading:20733579-Female, pubmed-meshheading:20733579-Humans, pubmed-meshheading:20733579-Keratin-18, pubmed-meshheading:20733579-Magnetic Resonance Imaging, pubmed-meshheading:20733579-Male, pubmed-meshheading:20733579-Middle Aged, pubmed-meshheading:20733579-Pyridines, pubmed-meshheading:20733579-Pyrimidines, pubmed-meshheading:20733579-von Willebrand Factor
pubmed:year	2010
pubmed:articleTitle	Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent.
pubmed:affiliation	Department of Medical Oncology, Royal Brisbane and Women's Hospital, Herston 4029, Queensland, Australia. jason.lickliter@med.monash.edu.au
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I